Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asthma; Eosinophilic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04612556
What this trial is testing

Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO)

Who this might be right for
Asthma; EosinophilicSevere AsthmaLate-Onset Asthma
Aristotle University Of Thessaloniki 45
Large-scale testing (Phase 3)Ended earlyNCT05813288
What this trial is testing

Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

Who this might be right for
Eosinophilic AsthmaAsthma; EosinophilicAsthma
Areteia Therapeutics 654
Post-approval studies (Phase 4)UnknownNCT06288516
What this trial is testing

BenRalizumab Effect on Airway Remodeling in Severe asTHma

Who this might be right for
Asthma; EosinophilicAirway Remodeling
Aristotle University Of Thessaloniki 45
Not applicableStudy completedNCT04221802
What this trial is testing

Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium

Who this might be right for
Severe Asthma
AstraZeneca 76
Large-scale testing (Phase 3)Looking for participantsNCT07671001
What this trial is testing

Depemokimab in Participants of 6 to 11 Years of Age

Who this might be right for
Asthma
GlaxoSmithKline 34
Not applicableLooking for participantsNCT06422078
What this trial is testing

A Non-interventional, Prospective Study With Benralizumab

Who this might be right for
Asthma, Bronchial
AstraZeneca 300
Not applicableLooking for participantsNCT05584488
What this trial is testing

Allergy and Immunology Natural History Study

Who this might be right for
Immune DeficiencyImmune Dysregulation DisorderAllergic Inflammation
Columbia University 10,000
Post-approval studies (Phase 4)UnknownNCT04585997
What this trial is testing

Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".

Who this might be right for
AsthmaEosinophilic Asthma
University of Newcastle, Australia 200
Large-scale testing (Phase 3)Looking for participantsNCT06979323
What this trial is testing

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

Who this might be right for
Asthma
GlaxoSmithKline 150
Early research (Phase 1)UnknownNCT05584306
What this trial is testing

A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT03610685
What this trial is testing

Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma

Who this might be right for
Asthma
NHS Greater Glasgow and Clyde 33
Large-scale testing (Phase 3)Study completedNCT01270464
What this trial is testing

Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 315
Testing effectiveness (Phase 2)Looking for participantsNCT07323654
What this trial is testing

KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Kymera Therapeutics, Inc. 264
Testing effectiveness (Phase 2)Study completedNCT04046939
What this trial is testing

Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma

Who this might be right for
Eosinophilic AsthmaAsthma
Knopp Biosciences 534
Not applicableNot Yet RecruitingNCT06911775
What this trial is testing

Eosinophil Subpopulations in Eosinophilic-associated Diseases

Who this might be right for
Eosinophilic AsthmaEosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilic Syndrome (HES)
University of Florence 160
Large-scale testing (Phase 3)Study completedNCT01508936
What this trial is testing

Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma

Who this might be right for
Eosinophilic Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 511
Large-scale testing (Phase 3)Study completedNCT02281318
What this trial is testing

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control

Who this might be right for
Asthma
GlaxoSmithKline 556
Testing effectiveness (Phase 2)Study completedNCT03469934
What this trial is testing

Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
AnaptysBio, Inc. 25
Post-approval studies (Phase 4)Study completedNCT04710134
What this trial is testing

Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma

Who this might be right for
Asthma; Eosinophilic
McMaster University 10
Post-approval studies (Phase 4)Enrolling By InvitationNCT07343661
What this trial is testing

Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

Who this might be right for
EGPA - Eosinophilic Granulomatosis With PolyangiitisSevere AsthmaEosinophilic Asthma
Azienda Ospedaliero Universitaria di Cagliari 90
Next Page